Cargando…
Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura
Approximately 40% of patients who survive acute episodes of thrombotic thrombocytopenic purpura (TTP) associated with severe acquired ADAMTS13 deficiency experience one or more relapses. Risk factors for relapse other than severe ADAMTS13 deficiency and ADAMTS13 autoantibodies are unknown. ADAMTS13...
Autores principales: | Edgar, Contessa E., Terrell, Deirdra R., Vesely, Sara K., Wren, Jonathan D., Dozmorov, Igor M., Niewold, Timothy B., Brown, Michael, Zhou, Fang, Frank, Mark Barton, Merrill, Joan T., Kremer Hovinga, Johanna A., Lämmle, Bernhard, James, Judith A., George, James N., Farris, A. Darise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324966/ https://www.ncbi.nlm.nih.gov/pubmed/25671313 http://dx.doi.org/10.1371/journal.pone.0117614 |
Ejemplares similares
-
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura
por: Borogovac, Azra, et al.
Publicado: (2020) -
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017
por: van Dorland, Hendrika A., et al.
Publicado: (2019) -
Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
por: Little, Dustin J., et al.
Publicado: (2017) -
Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017) -
Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)